Restricted accessResearch articleFirst published online 2010-10
Uncaria rhynchophylla Inhibits the Production of Nitric Oxide and Interleukin-1β Through Blocking Nuclear Factor κB,Akt,and Mitogen-Activated Protein Kinase Activation in Macrophages
The stems with hook of Uncaria rhynchophylla have been used in traditional medicine as an antipyretic, antihypertensive, and anticonvulsant in China and Korea. In this study, we investigated the mechanism responsible for anti-inflammatory effects of U. rhynchophylla in RAW 264.7 macrophages. The aqueous extract of U. rhynchophylla inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) and interleukin (IL)-1β secretion as well as inducible NO synthase (iNOS) expression, without affecting cell viability. Furthermore, U. rhynchophylla suppressed LPS-induced nuclear factor κB (NF-κB) activation, phosphorylation, and degradation of inhibitory protein IκB (IκB)-α, phosphorylation of Akt, extracellular signal-regulated kinase 1/2, p38 kinase, and c-Jun N-terminal kinase. These results suggest that U. rhynchophylla has the inhibitory effects on LPS-induced NO and IL-1β production in macrophages through blockade in the phosphorylation of Akt and mitogen-activated protein kinases, following IκB-α degradation and NF-κB activation.
Get full access to this article
View all access options for this article.
References
1.
HsiehCL, ChenMF, LiTCet al.Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack. in rats with kainic acid-induced epileptic seizure. Am J Chin Med, 1999; 27:257–264.
2.
MatsumotoK, MorishigeR, MurakamiYet al.Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies. Eur J Pharmacol, 2005; 517:191–199.
3.
HuXY, SunAS, SuiYX. Effects of combined use of total alkaloids of Uncaria rhynchophylla and Coryadlis ambailis migo on cerebral ischemia-reperfusion injury in rats [in Chinese]Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007; 27:1007–1009.
4.
LeeJ, SonD, LeePet al.Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-d-aspartate in rat hippocampus. J Pharmacol Sci, 2003; 92:70–73.
5.
LiuW, ZhangZQ, ZhaoXM, GaoYS. Protective effect of Uncaria rhynchophylla total alkaloids pretreatment on hippocampal neurons after acute hypoxia [in Chinese]Zhongguo Zhong Yao Za Zhi, 2006; 31:763–765.
6.
AhnDK. Illustrated Book of Korean Medicinal Herbs. Kyohak Publishing Co.: Seoul, 2003.
7.
ShiJS, YuJX, ChenXP, XuRX. Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin, 2003; 24:97–101.
8.
OzakiY. Vasodilative effects of indole alkaloids obtained from domestic plants, Uncaria rhynchophylla Miq. and Amsonia elliptica Roem. et Schult. Nippon Yakurigaku Zasshi, 1990; 95:47–54.
9.
ZhangWB, ChenCX, SimSM, KwanCY. In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)Naunyn Schmiedebergs Arch Pharmacol, 2004; 369:232–238.
10.
SukK, KimSY, LeemKet al.Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats. Life Sci, 2002; 70:2467–2480.
11.
KuramochiT, ChuJ, SugaT. Gou-teng (from Uncaria rhynchophylla Miquel)-induced endothelium-dependent and -independent relaxations in the isolated rat aorta. Life Sci, 1994; 54:2061–2069.
12.
HorieS, YanoS, AimiN, SakaiS, WatanabeK. Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta. Life Sci, 1992; 50:491–498.
13.
LeeJS, KimJ, KimBY, LeeHS, AhnJS, ChangYS. Inhibition of phospholipase Vgamma1 and cancer cell proliferation by triterpene esters from Uncaria rhynchophylla. J Nat Prod, 2000; 63:753–756.
14.
HsiehCL, TangNY, ChiangSY, HsiehCT, LinJG. Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata Bl., in kainic acid-treated rats. Life Sci, 1999; 65:2071–2082.
15.
LinJM, LinCC, ChenMF, UjiieT, TakadaA. Studies on Taiwan folk medicine, thang-kau-tin (II): measurement of active oxygen scavenging activity using an ESR technique. Am J Chin Med, 1995; 23:43–51.
16.
LiuJ, MoriA. Antioxidant and free radical scavenging activities of Gastrodia elata Bl. and Uncaria rhynchophylla (Miq.) Jacks. Neuropharmacology, 1992; 31:1287–1298.
17.
KimDY, JungJA, KimTH, SeoSW, JungSK, ParkCS. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice. J Ethnopharmacol, 2009; 122:567–572.
18.
YuanD, MaB, WuCet al.Alkaloids from the leaves of Uncaria rhynchophylla and their inhibitory activity on NO production in lipopolysaccharide-activated microglia. J Nat Prod, 2008; 71:1271–1274.
19.
YuanD, MaB, YangJYet al.Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. Int Immunopharmacol, 2009; 9:1549–1554.
20.
MedzhitovR, JanewayCAJr. Innate immunity: the virtues of a nonclonal system of recognition. Cell, 1997; 91:295–298.
21.
LuscinskasFW, GimbroneMAJr. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med, 1996; 47:413–421.
22.
DiehlS, RinconM. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol, 2002; 39:531–536.
23.
MahidaYR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis, 2000; 6:21–33.
24.
LiQ, VermaIM. NF-kappaB regulation in the immune system. Nat Rev Immunol, 2002; 2:725–734.
CobbMH, GoldsmithEJ. How MAP kinases are regulated. J Biol Chem, 1995; 270:14843–14846.
27.
KimSH, KimJ, SharmaRP. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res, 2004; 49:433–439.
28.
GuhaM, MackmanN. LPS induction of gene expression in human monocytes. Cell Signal, 2001; 13:85–94.
29.
SchmidtHHHW, KelmM. Determination of nitrite and nitrate by the Griess reaction. Methods in Nitric Oxide Research. FeelischM, StamlerJ. John Wiley & Sons: New York, 1996; 491–497.
30.
XieQW, KashiwabaraY, NathanC. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem, 1994; 269:4705–4708.
31.
LowensteinCJ, AlleyEW, RavalPet al.Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA, 1993; 90:9730–9734.
32.
LeeJC, KumarS, GriswoldDE, UnderwoodDC, VottaBJ, AdamsJL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology, 2000; 47:185–201.
33.
XiaoZY, ZhouWX, ZhangYXet al.Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Immunol Lett, 2007; 114:81–85.
34.
DanHC, CooperMJ, CogswellPC, DuncanJA, TingJP, BaldwinAS. Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev, 2008; 22:1490–1500.
35.
HattoriY, HattoriS, KasaiK. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Eur J Pharmacol, 2003; 481:153–158.
36.
LiX, TupperJC, BannermanDD, WinnRK, RhodesCJ, HarlanJM. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun, 2003; 71:4414–4420.
37.
MadridLV, MayoMW, ReutherJY, BaldwinASJr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem, 2001; 276:18934–18940.
38.
MinhajuddinM, BijliKM, FazalFet al.Protein kinase C-δ and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-κB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J Biol Chem, 2009; 284:4052–4061.
39.
PelletierJP, JovanovicD, FernandesJCet al.Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum, 1998; 41:1275–1286.
40.
LohinaiZ, BenedekP, FehérEet al.Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol, 1998; 123:353–360.
41.
ShinT, TanumaN, KimSet al.An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J Neuroimmunol, 1998; 92:133–138.
42.
HuaLL, LiuJS, BrosnanCF, LeeSC. Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis. Ann Neurol, 1998; 43:384–387.
43.
LevyB, ValtierM, de ChillouC, BollaertPE, CaneD, MallieJP. Beneficial effects of l-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats. Shock, 1999; 11:98–103.
44.
BlackwellTS, BlackwellTR, HoldenEP, ChristmanBW, ChristmanJW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol, 1996; 157:1630–1637.
45.
PierceJW, SchoenleberR, JesmokGet al.Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem, 1997; 272:21096–21103.
46.
LewisAJ, ManningAM. New targets for anti-inflammatory drugs. Curr Opin Chem Biol, 1999; 3:489–494.
47.
SegainJP, Raingeard, de la BletiereDet al.Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut, 2000; 47:397–403.
48.
KimYH, LeeSH, LeeJY, ChoiSW, ParkJW, KwonTK. Triptolide inhibits murine-inducible nitric oxide synthase expression by downregulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. Eur J Pharmacol, 2004; 494:1–9.
49.
KyriakisJM, AvruchJ. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem, 1996; 271:24313–24316.
50.
CiallellaJR, SaporitoM, LundSet al.CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice. Eur J Pharmacol, 2005; 515:179–187.
51.
HemmingsBA. Akt signaling: linking membrane events to life and death decisions. Science, 1997; 275:628–630.
52.
KandelES, HayN. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res, 1999; 253:210–229.
53.
WeichhartT, SaemannMD. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis, 2008; 67,Suppl 3:iii70–iii74.
